1.Bone marrow trephine biopsy findings in chronic myeloid leukemia.
Yookarin Khonglah ; Debdatta Basu ; Tarun Kumar Dutta
The Malaysian journal of pathology 2002;24(1):37-43
Sixty patients with chronic myeloid leukemia (CML) underwent bone marrow trephine biopsy at presentation. All the biopsies were decalcified, paraffin-embedded and stained with H&E, Gomori's reticulin and Masson Trichrome. A detailed study of the histology including the morphology and topographic distribution of megakaryocytes was done. 55 patients presented in chronic phase. Of these there were 37 cases (67%) of CML-granulocytic (CML-G) type and 18 cases (33%) of CML-granulocytic megakaryocytic (CML -GM) type. Five cases presented in blast crisis. 73% of CML-G had low-grade fibrosis while 83% of CML-GM had high-grade fibrosis. This was statistically significant. On follow-up 25% of CML-G went into blast crisis while all the CML-GM patients remained stable to date. Bone marrow biopsy is a useful investigation in patients of CML at diagnosis as it provides prognostic information. Evaluation of megakaryopoiesis, grading of fibrosis and localization of blasts are possible on a trephine biopsy.
BCR Gene
;
biopsy characteristics
;
upper case gee
;
Myeloid Leukemia, Chronic
;
Fibrosis
2.Role of (68)Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids.
Tarun JINDAL ; Arvind KUMAR ; Balasubramanian VENKITARAMAN ; Roman DUTTA ; Rakesh KUMAR
The Korean Journal of Internal Medicine 2010;25(4):386-391
BACKGROUND/AIMS: Although carcinoid tumors usually have good prognosis, early and specific diagnosis is important. Computed tomography and magnetic resonance imaging do not provide findings that are specific for carcinoids, and somatostatin receptor scintigraphy suffers from low spatial resolution. 18-Fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) has limited sensitivity for carcinoids due to low uptake of the marker. A PET/CT system that uses the somatostatin receptor-based PET tracer 1,4,7,10-tetraazacyclododecane-N(I),N(II),N(III),N(IIII)-tetraacetic acid (D)-Phe(1)-thy(3)-octreotide ((68)Ga-DOTATOC) has also been used in the evaluation of carcinoids, although information regarding its use for the detection of primary pulmonary carcinoids is limited. Thus, we investigated the value of (68)Ga-DOTATOC PET/CT for the diagnosis of primary pulmonary carcinoid tumors. METHODS: This was a retrospective analysis of patients with primary pulmonary tumors who underwent (68)Ga-DOTATOC PET/CT. All the patients had a histopathologic diagnosis of carcinoid. The rate of detection of primary pulmonary carcinoid tumors using (68)Ga-DOTATOC PET/CT was assessed. RESULTS: Twenty patients were diagnosed as having carcinoid, and 19 tumors showed significant uptake on (68)Ga-DOTATOC (detection rate, 95%). The maximal standardized uptake value (SUV(max)) ranged from 1.1 to 66, with a median value of 21.6. In one patient, (68)Ga-DOTATOC PET/CT revealed additional lesions. CONCLUSIONS: Our results demonstrate that (68)Ga-DOTATOC PET/CT is useful in the evaluation of primary pulmonary carcinoids and should be included in the diagnostic work-up of these patients.
Adolescent
;
Adult
;
Carcinoid Tumor/*diagnosis/radiography/radionuclide imaging
;
Female
;
Gallium Radioisotopes/*diagnostic use
;
Humans
;
Lung Neoplasms/*diagnosis/radiography/radionuclide imaging
;
Male
;
Middle Aged
;
Octreotide/*analogs & derivatives/diagnostic use
;
Positron-Emission Tomography/*methods
;
Radiopharmaceuticals/*diagnostic use
;
Retrospective Studies
;
Tomography, X-Ray Computed/*methods